|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based incentive compensation | |||||
| Profit sharing expense | |||||
| Loss on debt redemption and refinancing activities | |||||
| Impairment of debt investment | |||||
| Provision for allowance for credit losses on trade receivables | |||||
| Provisions for inventory obsolescence | |||||
| Deferred taxes, net | |||||
| Net (gain) loss on disposal/sale of businesses | |||||
| Impairment loss on equity investments, net | |||||
| Other non-cash items | |||||
| Changes in operating assets and liabilities: | |||||
| Trade receivables, net | |||||
| Inventories, net | |||||
| Income tax receivable/payable | |||||
| Accounts payable | |||||
| Customer advance payments | |||||
| Tax refunds (payments and deposits) to resolve certain prior years' tax matters | |||||
| Other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Proceeds related to sale of businesses and property and equipment, net | |||||
| Businesses acquired in purchase transactions, net of cash acquired | |||||
| (Payments) Proceeds associated with debt, equity, and equity method investments | |||||
| Proceeds from cross currency swaps and settlement of foreign currency forward contracts | |||||
| Cross-currency swaps | |||||
| Foreign currency forward contracts | |||||
| Proceeds of corporate owned life insurance | |||||
| Proceeds from cross-currency swaps | |||||
| Settlement of foreign currency forward contracts | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net (payments) proceeds of short-term borrowings | |||||
| Proceeds from long-term debt | |||||
| Payments of long-term debt | |||||
| Dividends paid on common stock | |||||
| Repurchases of common stock | |||||
| Payments for debt modification/extinguishment costs and other | |||||
| Impact of tax withholding on share-based compensation | |||||
| Principal payments related to financing leases | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of foreign currency exchange rate changes on cash and cash equivalents | |||||
| Cash and Cash Equivalents | |||||
| Restricted cash and cash equivalents | |||||
| Cash, cash equivalents, and restricted cash, beginning of period | |||||
| Net change during the period | |||||
| Cash and cash equivalents | |||||
| Cash, cash equivalents, and restricted cash, end of period | |||||
| Supplemental Cash Flow Information: | |||||
| Interest payments, net of amounts capitalized | |||||
| Income tax payments, net of cash refunds | |||||
| Restructuring payments including associated costs | |||||
| Non-cash items: | |||||
| Transfers of shares of common stock from treasury for profit-sharing plan contributions | |||||
| Accrued capital expenditures | |||||
Loading...